Neoplasma : Impact Factor & More
eISSN: 1338-4317pISSN: 0028-2685
Share this on:
Key Metrics
CiteScore 
4.2
Impact Factor
< 5
SNIP
0.62
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Neoplasma
Neoplasma Journal Specifications
| Overview | |
| Publisher | AEPRESS SRO |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in Neoplasma ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Neoplasma
M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2.
- 15 Oct 2026
- Neoplasma
CtDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer.
- 15 Oct 2026
- Neoplasma
Tissue carcinoembryonic antigen as a superior independent prognostic factor for colorectal cancer over serum CEA: a retrospective cohort study.
- 5 Oct 2026
- Neoplasma
LAMTOR5-AS1 predicts poor prognosis and regulates glioma progression via miR-4653-5p/TCF7 axis.
- 5 Oct 2026
- Neoplasma
Transcriptomic analysis of vitamin D3 (cholecalciferol)-mediated attenuation of cisplatin sensitivity in gastric cancer cells in vitro.
- 7 Sep 2026
- Neoplasma
Afatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.
- 17 Aug 2026
- Neoplasma
M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2.
- 15 Oct 2026
- Neoplasma
CtDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer.
- 15 Oct 2026
- Neoplasma
Tissue carcinoembryonic antigen as a superior independent prognostic factor for colorectal cancer over serum CEA: a retrospective cohort study.
- 5 Oct 2026
- Neoplasma
LAMTOR5-AS1 predicts poor prognosis and regulates glioma progression via miR-4653-5p/TCF7 axis.
- 5 Oct 2026
- Neoplasma
Transcriptomic analysis of vitamin D3 (cholecalciferol)-mediated attenuation of cisplatin sensitivity in gastric cancer cells in vitro.
- 7 Sep 2026
- Neoplasma
Afatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.
- 17 Aug 2026
- Neoplasma
FAQs on Neoplasma
How long has Neoplasma been actively publishing? 
What is the publishing frequency of Neoplasma?
How many articles did Neoplasma publish last year?
What is the eISSN & pISSN for Neoplasma?
What is Citescore for Neoplasma?
What is SNIP score for Neoplasma?
Who is the publisher of Neoplasma?
